We specialize in evaluating the ability of CD8+ T cells and NK cells to target and eliminate infected or malignant cells, providing critical insights into immune-mediated cytotoxicity. Our studies offer valuable data for the development of immunotherapies that harness the power of CD8+ T cells and NK cells.